Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00588029 · ClinicalTrials.gov registry record

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

A clinical trial of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
7,000
Enrollment target
3
Study locations

NCT00588029: Active study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00588029 is a study of Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 7,000 participants, above the 2,798-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (150% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00588029, a study of Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
7,000 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes. These blood samples will be used by researchers at Memorial Sloan-Kettering Cancer Center who study the causes of breast cancer, as well as more effective ways to prevent, diagnose, and treat breast cancer.

Conditions Studied

Study Locations (3)

New York

  • Memorial Sloan-Kettering Cancer Center @ Suffolk - Commack
  • Memorial Sloan-Kettering Cancer - New York

New Jersey

  • Memorial Sloan Kettering Cancer Center - Basking Ridge

Trial Details

FieldValue
Enrollment Target 7,000 participants
Start Date 1999-07
Est. Completion 2026-12

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00588029

The ClinicalTrials.gov registry entry for NCT00588029 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 7,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,798-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (150% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00588029 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT00588029 about?

NCT00588029 is a clinical study titled "Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer". The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes. These blood samples will be used by researchers at Memorial Sloan-Kettering Cancer Center who study the causes...

What is the current status of trial NCT00588029?

This trial is currently active not recruiting. The enrollment target is 7,000 participants. The study started on 1999-07. Estimated completion is 2026-12.

What conditions does trial NCT00588029 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT00588029?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00588029 being conducted?

This trial has 3 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.